MedTrace Logo

Soft Exosuits for Functional Gait Recovery in Acute Stroke Rehabilitation

NCT06231511 · Status: COMPLETED · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2025-08-14

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to develop and evaluate the use of soft exosuits in patients post stroke.

Conditions

Interventions

DEVICE

Hip flexion soft exosuit

Participants will utilize a Wyss designed hip flexion soft exosuit. This device has a small rope winch at the front of the hip connected to a functional textile waistband and thigh band. It applies an assistive torque in response to wearable sensor measurements.

DEVICE

ReWalk ReStore soft exosuit

Participants will utilize the ReWalk ReStore ankle soft exosuit. This device provides dynamic plantarflexion and dorsiflexion during walking intended to restore paretic limb function resulting in improved gait symmetry, reduced energy cost of walking and improved stability. The exosuits consists of a body-worn actuation unit containing motors, gears, and pulleys that when powered generate forces that are transmitted via Bowden cables to functional textiles anchored proximal and distal to a joint. This actuation occurs in response to signals from embedded wearable sensors.

OTHER

Conventional physical therapy

Participants will complete conventional physical therapy without use of exosuits during the course of their inpatient rehabilitation stay.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-30
Primary Completion
2024-04-15
Completion
2024-04-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06231511 on ClinicalTrials.gov